Clinical Trials on Keratitis; Infectious Disease (Manifestation)

Total 90507 results

Tarek Hassanein
Shanghai Sundise Traditional Chinese Medicine Co., Ltd.

Completed

Assess the Antifibrotic Activity of Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic Fibrosis

Chronic Hepatitis C Infection

United States
Peking Union Medical College

Unknown

Observation on the Herpes Simplex Keratitis (OHSV)

Keratitis, Herpetic

China
Janssen Pharmaceutical K.K.

Completed

A Study to Investigate the Safety, Pharmacokinetics, and Efficacy of Combination Treatment of AL-335, Odalasvir, and Simeprevir in Japanese Participants With Chronic Hepatitis C Genotype 1 or 2 Virus Infection, With or Without Compensated Cirrhosis Who Are Direct Acting Antiviral Treatment-naive

Hepatitis C, Chronic

Japan
Charles University, Czech Republic
Institute for Clinical and Experimental Medicine; General University Hospital... and other collaborators

Completed

Biliverdin Reductase A in Chronic Hepatitis C Virus Infection

Hepatitis C, Chronic

Czech Republic
Boehringer Ingelheim

Completed

Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Chronic Hepatitis C Virus Infection

Hepatitis C, Chronic
University of Maryland, Baltimore
Gilead Sciences

Completed

Ledipasvir/Sofosbuvir for Hepatitis B Virus Infection (APOSTLE)

Hepatitis B

United States
University Health Network, Toronto

Recruiting

Pharmacist-led Hepatitis C Management (PHARM-C)

Hepatitis C Virus Infection

Canada
University of British Columbia
Canadian Institutes of Health Research (CIHR)

Completed

Evaluation of a Multi-disciplinary Approach for the Treatment of Hepatitis C in IDUs (HI-LO Study)

Hepatitis C Virus Infection

Canada
Sunshine Lake Pharma Co., Ltd.

Recruiting

Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C

Chronic HCV Infection

China
Kirby Institute
Gilead Sciences; The University of New South Wales

Completed

Tenofovir in HIV/HBV Coinfection (TICO)

HIV Infection | Hepatitis B Coinfection

Australia, Thailand
The HIV Netherlands Australia Thailand Research...
Kirby Institute; Ministry of Health, Thailand

Completed

HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infection

HIV | Hepatitis-B

Thailand
Astellas Pharma Inc
Astellas Pharma US, Inc.

Completed

Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection

Hepatitis C

United States
Green Cross Corporation

Completed

A Phase 2 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in HBV-related Liver Transplant Recipients

Hepatitis B Infection

Korea, Republic of
VA Office of Research and Development
GlaxoSmithKline

Completed

Herpes Simplex Type 1 Suppression in Hepatitis C (HSV1/HCV)

Chronic Hepatitis C Infection

United States
Gilead Sciences

Completed

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Participants With Chronic Genotype 1 HCV Infection

Chronic HCV Infection

China, Korea, Republic of, Taiwan
Gilead Sciences

Completed

Safety and Efficacy of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Chronic Genotype 1 or 3 HCV Infection

Chronic HCV Infection

India
Gilead Sciences

Completed

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy

Hepatitis C Virus Infection

Egypt
University College, London

Unknown

HepCare: The Effectiveness of Community Based Interventions With Peer Support to Improve Case Detection, Carry Out Pre-treatment Assessments and Assist Underserved Populations Through HCV Treatment

Hepatitis C | Infectious Disease

United Kingdom
Beni-Suef University

Completed

Sofosbuvir Plus Daclatasvir With or Without Ribavirin and Chronic HCV Genotype (GT) 4

Chronic Hepatitis C Virus Infection
Janssen R&D Ireland

Terminated

Study in HCV-Infected Patients to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of JNJ-47910382

Chronic Hepatitis C Infection

Germany
Anna Cruceta

Completed

HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin (BOC-HIV)

HIV Infections | Hepatitis C | COINFECTION

Spain
Sunshine Lake Pharma Co., Ltd.

Completed

Phase 2 Study of Yimitasvir Phosphate Capsules

Chronic HCV Infection

China
Carmel Medical Center

Unknown

The Epidemiology of Hepatitis E Virus Infection in Israel and Potential Risk Factors

Chronic Hepatitis E
Kirby Institute

Completed

Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison Setting (SHARP-P)

Hepatitis C, Chronic

Australia
Merck Sharp & Dohme LLC

Completed

To Evaluate the Effect of Ritonavir or Omeprazole on the Pharmacokinetics of Samatasvir (IDX719) in Healthy Participants (MK-1894-006)

Chronic Hepatitis C Infection
Merck Sharp & Dohme LLC

Completed

A Study of 2 Doses of VAQTA™ in Healthy Children 12 to 23 Months of Age (V251-069)

Hepatitis A Virus Infection
International Centre for Diarrhoeal Disease Research...

Completed

Non Inferiority Trial of Locally Manufactured 'Hepa-B' Vaccine in Bangladesh.

Hepatitis B Infection

Bangladesh
Gilead Sciences

Completed

Ledipasvir/Sofosbuvir Fixed-Dose Combination With Ribavirin or GS-9669 in Subjects With Chronic Genotype 1 HCV Infection

Chronic HCV Infection

United States
Gilead Sciences

Completed

Efficacy and Safety of Sofosbuvir/Ledipasvir ± Ribavirin in Japanese Participants With Chronic Genotype 1 HCV Infection

Chronic HCV Infection

Japan
Gilead Sciences

Completed

Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment (Co-STARs)

HIV-1 Infection | HCV Infection

United States, Puerto Rico
Beijing Ditan Hospital

Recruiting

Study of COVID-19 Infection and Its Clinical Prognosis in Chronic Hepatitis B Patients With Antiviral Therapy

Chronic Hepatitis B | COVID-19 Infection

China
University of Wuerzburg

Withdrawn

Evaluation of Neurocognitive Performance in Drug Substituted Patients Under Hepatitis C Therapy

Chronic Hepatitis C Infection

Germany
AbbVie

Completed

A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2) (EXPEDITION-2)

Hepatitis C Virus Infection | Chronic Hepatitis C | Human Immunodeficiency Virus Infection | Compensated Cirrhosis and Non-cirrhotics
AbbVie

Completed

A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection (TURQUOISE-I)

Hepatitis C Virus Infection | Chronic Hepatitis C | Human Immunodeficiency Virus Infection | Compensated Cirrhosis and Non-cirrhotics
Cairo University

Completed

Oral Microbiome of Patients With Hepatitis C Virus Infection

Hepatitis C Viral

Egypt
Gilead Sciences

Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfection

Hepatitis C Virus Infection

Taiwan
Kirby Institute

Completed

Treatment of Recently Acquired Hepatitis C Virus Infection (ATAHC-II)

Acute Hepatitis C

Australia
Zhongshan Hospital Xiamen University

Unknown

Study on Gut Microbiota in Chronic HBV Infected Patients (HBV)

Healthy | Chronic Hepatitis B Infection

China
ANRS, Emerging Infectious Diseases
Université Montpellier; Centre Muraz

Active, not recruiting

Cross Sectional Survey on the Burden, Impacts and Causes of Hepatitis C Virus (HCV) Outbreak in South West Region in Burkina Faso (REVERSO)

Chronic Hepatitis c | Hepatitis C Virus Infection, Past or Present

Burkina Faso
Janssen Infectious Diseases BVBA
Vertex Pharmaceuticals Incorporated

Completed

VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection

Genotype 1 Chronic Hepatitis C | Treatment Naive

United States, Australia, France, Poland, United Kingdom, Belgium, Germany, Spain, Sweden, Brazil, Austria, Ireland, Mexico
Digna Biotech S.L.

Completed

A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C

Chronic Hepatitis C Virus Infection | Genotype 1 | Treatment-Experienced Patients | Relapses

Spain
Gilead Sciences

Completed

Safety and Efficacy of Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection

Hepatitis C Virus Infection

Estonia, Russian Federation
Green Cross Corporation

Unknown

HBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102

Hepatitis B Infection

Korea, Republic of
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance

HIV-1 and Hepatitis C Co-Infection

United States
AbbVie (prior sponsor, Abbott)

Completed

Study to Assess the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of ABT-267 in HCV Infected Subjects

Chronic Hepatitis C Infection

United States
Merck Sharp & Dohme LLC

Completed

Study to Evaluate Drug-Drug Interaction Between IDX719 and Simeprevir in Healthy Participants (MK-1894-004)

Chronic Hepatitis C Infection
Virobay Inc.

Completed

Evaluation of Safety and Pharmacokinetics of Single Doses of VBY-376 in Healthy Adults

Chronic Hepatitis C Infection

United States
ANRS, Emerging Infectious Diseases

Recruiting

Study of DAA Treatment for Children and Adolescents With Active HCV Infection in Cambodia (HEPEDIAC)

HCV Infection

Cambodia
Nanjing Sanhome Pharmaceutical, Co., Ltd.

Completed

Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of SH229 in Patients With HCV Infection

HCV Infection

China
National Institutes of Health Clinical Center (CC)

Completed

Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection

Hepatitis B | Hepatitis C

United States

3

Subscribe